RxDoctor Payments Data

Jared Smith

Family · Chillicothe, OHNPI 1356079727

Payments from drug & device makers

$1,396in general payments, 2019–2025

Across 92 payments — averaging $15.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$246
  • Novo Nordisk$196
  • Lilly USA, LLC$160
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$132
  • Otsuka America Pharmaceutical, Inc.$120
  • Teva Pharmaceuticals USA, Inc.$105
  • plus $437 from 11 others

What the payments were for

  • Food & beverage$1,396100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,396 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$132,019
Medicare patients
188
Services billed
2,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide19$19,488
MounjaroTirzepatide12$15,472
TrulicityDulaglutide12$12,042
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen299$5,274
JardianceEmpagliflozin14$4,263
Pregabalin40$2,691
BelsomraSuvorexant13$2,047
Lacosamide29$1,803
Lorazepam202$1,624
Tramadol Hcl132$1,332
Gabapentin73$1,219
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen63$1,174
Clonazepam84$950
Divalproex Sodium11$667
Potassium Chloride12$494

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$160$27,51524 claims
Novo NordiskOzempic$196$19,48819 claims
Boehringer IngelheimJardiance$52$4,26314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Chillicothe

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →